|

L19IL2/L19TNF Clinical Trials

3 actively recruiting trials across 2 locations

▲ +1 trial since July 2026

Also known as: Daromun

Pipeline

Phase 2: 3

Top Sponsors

  • Philogen S.p.A.3

Indications

  • Cancer3
  • Locally Advanced Basal Cell Carcinoma2
  • Melanoma Stage III1
  • Melanoma Stage IV1

Tampa, Florida2 trials

L19IL2 or L19TNF or L19IL2/TNF in Patients With Basal Cell Carcinoma (BCC)

H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc.

Phase 2
L19IL2/TNF in Patients With Basal Cell Carcinoma

H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc.

Phase 2

New York, New York1 trial

Study of the Efficacy of Intratumoral L19IL2 or L19TNF or L19IL2/L19TNF, in Combination with Pembrolizumab, in Unresectable Melanoma Patients

Memorial Sloan Kettering Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.